Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lisuride hydrogen maleate

EU orphan designation number: EU/3/11/869   
Active ingredient: Lisuride hydrogen maleate
Indication: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Sponsor: Sinoxa Pharma GmbH
Königin-Luise-Str. 27, D-14195 Berlin, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/05/2011 Centralised Orphan - Designation EMA/OD/138/10 (2011)3495 of 13/05/2011
12/11/2012 Other procedure